Ipsen Banner Image


  • Ticker
  • Industry Drug Manufacturers - Major More
  • Sector Healthcare More
Ipsen Logo Image
  • 1001-5000 Employees
  • Based in Paris, France
Ipsen is a global specialty-driven biopharmaceutical group focused on innovation and Specialty Care. It develops and commercializes innovative medicines in three key therapeutic areas - Oncology, Neuroscience and Rare Disease. Its commitment to oncology is exemplified through its growing portfolio of key therapies for prostate cancer, neuroendocrine tumors, renal cell carcinoma and pancreaticMore cancer. Neuroscience is advancing at an unprecedented rate and Ipsen is at the forefront of this transformation. Ipsen also has a well-established Consumer Healthcare business. With total sales close to €2.5 billion in 2020, Ipsen sells more than 20 drugs in over 115 countries, with a direct commercial presence in more than 30 countries. Ipsen's R&D is focused on its innovative and differentiated technological platforms located in the heart of the leading biotechnological and life sciences hubs (Paris-Saclay, France; Oxford, UK; Cambridge, US). The Group has about 5,700 employees worldwide.

Most Recent Responsibility Report

MOST RECENT 2022 Responsibility Report

Ipsen does not currently have any hardcopy reports on ResponsibilityReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Archived Responsibility Reports

Our service enables potential investors to review the most recent and archived Ipsen Sustainability Report, Ipsen Corporate Social Responsibility Report, Ipsen CSR Report, Ipsen Corporate Responsibility, Ipsen CR Report, Ipsen Citizenship Report, Ipsen ESG Report, and Ipsen Environmental Report online.
Ipsen Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!